SC
CEMI

Sophrosyne Capital’s Chembio diagnostics, Inc. CEMI Stock Holding History

Sophrosyne Capital’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-103,400
Closed -$407K – 45
2014
Q4 		$407K Buy
+103,400
New +$428K 0.63% 29

Other funds holding CEMI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sophrosyne Capital's CEMI Position: Q1 2015 in Review

Sophrosyne Capital sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2015, closing a stake of 103,400 shares — an estimated $407K sold.

Sophrosyne Capital first reported a position in CEMI in Q4 2014 and held it in 1 quarter. The position peaked at $407K in Q4 2014. 23 funds tracked by Wall St. Rank hold CEMI as of Q1 2015.

  • Sophrosyne Capital reported no remaining Chembio diagnostics, Inc. position as of Q1 2015 after selling out during the quarter.
  • Sophrosyne Capital sold 103,400 Chembio diagnostics, Inc. shares in Q1 2015, an estimated $407K.
  • Sophrosyne Capital first reported a position in Chembio diagnostics, Inc. in Q4 2014 and held it in 1 quarter.
  • Sophrosyne Capital's Chembio diagnostics, Inc. position peaked at $407K in Q4 2014.
  • 23 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2015.

Based on Sophrosyne Capital's 13F filing for Q1 2015, filed 20 Apr 2015.